The vision of the Oncology Department is to transcend boundaries to lead discovery and its translation into transformative clinical investigations, education, and compassionate patient care that will provide cures for childhood cancer and ensure quality of life across the patient’s lifespan.
Our Oncology faculty are world leaders in identifying novel drugs and treatment modalities, defining the clinical significance of recently discovered genetic abnormalities of cancer cells, understanding mechanisms of cancer development and drug resistance, identifying children at risk for the development of cancer, and understanding and preventing late effects of therapy. We aim to share our unique clinical expertise with colleagues nationally through our many clinical trial consortia and worldwide through our partnership with St. Jude Global. The ultimate goal of our research is to ensure that every child with cancer receives curative therapy and that this therapy allows them the potential for a healthy, long-lasting life.
About the Chair
View Details
Julie R. Park, MD
Member, St. Jude Faculty
Chair, Department of Oncology
Associate Director Comprehensive Cancer Center, Translational Research
Endowed Chair in Pediatric Oncology
Julie R. Park, MD
Member, St. Jude Faculty
Chair, Department of Oncology
Associate Director Comprehensive Cancer Center, Translational Research
Dr. Julie R. Park is a pediatric hematologist-oncologist who is interested in developing and advancing new approaches to childhood cancer therapy. Dr. Park received her MD from the University of Vermont and completed residency training in pediatrics at the University of Washington. Dr. Park then completed a fellowship in pediatric hematology/oncology at the University of Washington and Fred Hutchinson Cancer Research Center.
She has been funded as a Fellow for the Leukemia Society of America at Fred Hutchinson Cancer Research Center, and an investigator on NCI and NIH grants. As a Member of the St. Jude Faculty and Chair of the Oncology Department, Dr. Park is interested in discovering the molecular and immunologic vulnerabilities of solid tumor malignancies, such as neuroblastoma, and using this information to inform clinical trials centered on novel therapies for children with relapsed or refractory high-risk tumors.
The Division of Cancer Predisposition promotes cutting-edge clinical, translational and basic research related to genetic predisposition to childhood cancer.
The Division of Cancer Survivorship at St. Jude Children's Research Hospital strives to improve quality of life among adult survivors of pediatric cancer.
The Division of Molecular Oncology investigates the molecular and cellular determinants that lead to tumor formation and that dictate cellular responses to cytotoxic stresses.
The Neuro-Oncology division at St. Jude works advances knowledge related to the etiology, biology, treatment, and eventually cures of brain tumors in children
The Division of Quality of Life & Palliative Care provides patient and family-centered care promoting holistic symptom management, care coordination and support to optimize quality of life.
The Solid Tumor division develops and tests novel therapeutics for the treatment of pediatric solid tumors, particularly those at high risk of treatment failure
St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.
St. Jude investigators have the freedom to focus on making big discoveries, backed by extraordinary resources and support teams. We are always looking for highly motivated scientists and engineers with passion and talent to join us!
